文献速递耳科与耳神经

全国队列数据提示严重精神疾病与听力学听力损失之间存在关联

National Cohort Data Suggests an Association Between Serious Mental Illness and Audiometric Hearing Loss.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-04-12

该横断面流行病学研究纳入7581名美国西班牙裔成人,采用多变量线性回归分析严重精神疾病(SMI)与听力损失(HL)的关联。结果显示,使用HCHS定义抗精神病药者听力较未使用者差3.75 dB(95%CI 2.36-5.13,P<.001),使用SMI特异性抗精神病药者差4.49 dB(95%CI 2.56-6.43,P<.001)。

要点

  • 使用HCHS定义抗精神病药与听力差3.75 dB相关(95%CI 2.36-5.13,P<.001)。
  • 使用SMI特异性抗精神病药与听力差4.49 dB相关(95%CI 2.56-6.43,P<.001)。
  • SMI与听力损失的因果关系方向尚不明确,需进一步研究。

核心结论

  • 以使用HCHS定义抗精神病药或使用SMI特异性抗精神病药定义的SMI,在控制潜在混杂因素后与更差的听力相关。
  • SMI是否导致HL、抗精神病药是否通过耳毒性导致HL、或HL是否导致SMI尚不清楚,需进一步研究。

研究设计与样本

  • 横断面流行病学研究(西班牙裔社区健康研究),纳入美国多中心志愿者。
  • 共7581名受试者具有完整数据,平均年龄55.2岁(SD=7.5岁),较好耳平均纯音听阈16.8 dB(SD=10.7 dB)。

主要发现

  • 194名(2.6%)受试者使用HCHS定义抗精神病药,98名(1.3%)使用至少1种SMI特异性抗精神病药。
  • 多变量回归显示,使用HCHS分类抗精神病药者较未使用者听力差3.75 dB(95%CI 2.36-5.13,P<.001)。
  • 使用SMI特异性抗精神病药者较未使用者听力差4.49 dB(95%CI 2.56-6.43,P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • SMI是否导致HL、抗精神病药是否通过耳毒性导致HL、或HL是否导致SMI尚不清楚,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore whether there is an association between serious mental illness (SMI) and hearing loss (HL) among US Hispanic adults. STUDY DESIGN AND SETTING: Cross-sectional epidemiological study (Hispanic Community Health Study), including multicentered US volunteers. METHODS: Multivariable linear regressions were conducted to study the association between SMI and HL. Adjustments were made for potential confounders including age, sex, education, vascular disease (hypertension or diabetes mellitus), and cognition. SMI was defined by (1) antipsychotic medication classification and (2) the use of at least 1 antipsychotic medication specifically used to treat SMI in clinical psychiatric practice. HL was measured by pure tone audiometry. RESULTS: A total of 7581 subjects had complete data. The mean age was 55.2 years (SD = 7.5 years) and the mean pure tone average in the better ear was 16.8 dB (SD = 10.7 dB). A total of 194 (2.6%) subjects were taking a HCHS-defined antipsychotic and 98 (1.3%) were taking at least 1 antipsychotic specifically used to treat SMI. On multivariable regression, use of HCHS's classified antipsychotics was associated with 3.75 dB worse hearing (95% confidence interval [CI] = 2.36-5.13, P < .001) and use of antipsychotics specific for SMI was associated with 4.49 dB worse hearing (95% CI = 2.56-6.43, P < .001) compared to those not using antipsychotics. CONCLUSION: SMI, as defined by either the use of HCHS-defined antipsychotics or the use of antipsychotic medication specific for SMI, is associated with worse hearing, controlling for potential confounders. Whether SMI contributes to HL, antipsychotic medication (through ototoxicity) contributes to HL, or whether HL contributes to SMI is unknown and warrants further investigation.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Alter IL, Tucker LH, Dragon JM, et al. National Cohort Data Suggests an Association Between Serious Mental Illness and Audiometric Hearing Loss. Otolaryngol Head Neck Surg. 2024. PMID: 38606639. doi:10.1002/ohn.763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。